Suboxone Settlement

On October 30, 2023, the Court overseeing the Suboxone Direct Purchaser Class litigation preliminarily approved a $385 million settlement, reached days before trial was scheduled to begin.  Faruqi and Faruqi are co-lead counsel for the Class, in this antitrust case involving allegations of monopolization and a product hop relating to the drug, Suboxone.  The Court has set a Final Fairness Hearing for February 27, 2024 in the United States District Court for the Eastern District of Pennsylvania.   

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885


3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania